Skip to main content
Equibles
GRAL logo

GRAL · GRAIL, Inc. · Held by Funds

Track GRAL — free

Use GRAL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GRAL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$115.89 -5.46 (-4.50%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$5.21B
Shares
44.96M
Volume · Nov 13 361.16K Avg daily vol (3M) 1.05M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of GRAL by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 15.24% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.76% 1,242,662
Index ETFs 12.48% 5,610,873
Active ETFs 0.81% 362,965
Active funds 7.12% 3,202,149
Unclassified 0.23% 101,461
All registered funds 23.40% 10,520,110
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding GRAL

239 fund positions
Fund Balance Value % of Fund Open
PRIMECAP Odyssey Aggressive Growth Fund 1,579,791 $108,310,471 1.46%
State Street(R) SPDR(R) S&P(R) Biotech ETF 1,425,535 $97,321,274 0.91%
VANGUARD TOTAL STOCK MARKET INDEX FUND 1,228,548 $83,872,972 0.00%
iShares Russell 2000 ETF 1,075,472 $73,422,473 0.09%
Fidelity Small Cap Index Fund 451,835 $30,977,808 0.09%
iShares Russell 2000 Value ETF 386,539 $26,389,018 0.18%
VANGUARD EXTENDED MARKET INDEX FUND 374,391 $25,559,674 0.03%
iShares Biotechnology ETF 280,947 $19,180,252 0.21%
VANGUARD RUSSELL 2000 INDEX FUND 236,696 $18,786,562 0.10%
Fidelity Extended Market Index Fund 159,525 $12,661,499 0.03%
Schwab U.S. Small-Cap ETF 155,741 $12,361,163 0.05%
VANGUARD CAPITAL OPPORTUNITY FUND 165,188 $11,277,385 0.03%
abrdn Healthcare Investors 151,885 $10,369,189 0.76%
T. Rowe Price Small-Cap Value Fund, Inc. 144,667 $9,876,416 0.09%
Dimensional U.S. Small Cap ETF 138,238 $9,477,597 0.06%
U.S. SMALL CAP PORTFOLIO 135,296 $9,275,894 0.05%
VANGUARD HEALTH CARE INDEX FUND 115,573 $9,173,029 0.04%
Inception Portfolio 131,943 $9,007,749 3.19%
EQ/Morgan Stanley Small Cap Growth Portfolio 122,618 $8,371,131 1.76%
U.S. MICRO CAP PORTFOLIO 111,262 $7,628,123 0.10%
Schwab Small-Cap Index Fund 100,326 $6,878,351 0.09%
Fidelity Enhanced Small Cap Core ETF 92,686 $6,327,673 0.11%
Dimensional U.S. Core Equity 2 ETF 89,559 $6,140,165 0.01%
Invesco RAFI US 1500 Small-Mid ETF 87,532 $6,001,194 0.22%
Avantis U.S. Small Cap Equity ETF 73,972 $5,871,158 0.19%
Nomura Healthcare Fund 85,000 $5,802,950 0.77%
abrdn Life Sciences Investors 77,618 $5,298,981 0.77%
Master Small Cap Index Series 75,438 $5,150,152 0.09%
Fidelity Total Market Index Fund 63,133 $5,010,866 0.00%
1290 VT GAMCO Small Company Value Portfolio 65,000 $4,437,550 0.10%
VANGUARD STRATEGIC EQUITY FUND 60,793 $4,150,338 0.03%
Fidelity Series Total Market Index Fund 50,610 $4,016,916 0.00%
Fidelity Small Cap Value Index Fund 57,749 $3,942,524 0.18%
Nuveen Small Cap Blend Index Fund 52,743 $3,616,060 0.09%
Direxion Daily S&P Biotech Bull 3X Shares 48,308 $3,311,996 0.67%
VANGUARD PRIMECAP CORE FUND 47,615 $3,250,676 0.02%
Franklin Biotechnology Discovery Fund 46,433 $3,183,446 0.28%
iShares Core S&P Total U.S. Stock Market ETF 45,469 $3,104,169 0.00%
VANGUARD RUSSELL 2000 VALUE INDEX FUND 38,709 $3,072,333 0.21%
EQ/2000 Managed Volatility Portfolio 44,889 $3,064,572 0.08%
BlackRock Advantage Small Cap Core Fund 36,665 $2,910,101 0.05%
Principal U.S. Small-Cap ETF 41,189 $2,811,973 0.12%
JNL Multi-Manager Small Cap Growth Fund 38,680 $2,640,684 0.10%
Fidelity Nasdaq Composite Index Fund 31,641 $2,511,346 0.01%
SLOW CAPITAL GROWTH FUND 36,000 $2,468,160 2.35%
PIMCO RAE US Small Fund 35,961 $2,455,057 0.06%
U.S. CORE EQUITY 2 PORTFOLIO 35,533 $2,436,142 0.01%
Victory Small Cap Stock Fund 35,064 $2,403,988 0.25%
Nuveen Equity Index Fund 33,148 $2,272,627 0.00%
LVIP State Street Small-Cap Index Fund 29,200 $1,993,484 0.09%
Showing 1–50 of 239 positions
Key facts CIK 1699031 CUSIP 384747101 13F (30d) 355 filings 321 filers Visit website Investor relations